Table 1

Demographic and clinical characteristics of study population
Whole Population n =132 TT n=37 TC n=70 CC n=25 p-value TT vs CC
Mean age (mean ± SD) 65.4±10.4 64.3 ± 12.1 65.5 ± 10.0 67.1 ± 9.0 ns
Gender (male), n (%) 108 (81.8) 32 (86.5) 57 (81.4) 19 (82.6) ns
Smoking habit, n (%) 77 (58.3) 19 (51.4) 46 (45.7) 10 (43.5) ns
Hypercholesterolemia n (%) 73 (55.3) 14 (37.8) 46 (65.7) 11 (47.8) ns
History of Hypertension, n (%) 45 (34.1) 9 (24.3) 25 (35.7) 9 (39.1) < 0.05
CAD Familiarity, n (%) 56 (42.4) 19 (51.4) 46 (65.7) 10 (43.5) ns
Obesity, n (%) 20 (15.2) 9 (2.4) 9 (1.3) 2 (0.9) ns
DCM Etiology, n (%) 21 (32) 32 (48) 13 (20) ns
IHD Etiology, n (%) 16 (24) 38 (58) 12 (18) ns
LV Ejection Fraction, % 37.7 ± 7.6 38.2 ± 8.4 38.0 ± 7.1 36.4 ± 7.9 ns
LVEF<40% & NYHA Class II-III 35 (26.5) 8 (22.8) 18 (51.4) 9 (25.7) ns
Glucose (mg/dL) ±SD 102.5 ± 23.4 95.5 ± 10.6 102.1 ± 25.3 114.2 ± 27.7 0.001
Insulin (mU/mL) ±SD 11.1 ± 7.3 9.5 ± 4.8 11.3 ± 8.3 12.9 ± 7.4 0.04
HOMA-IR ±SD 2.9 ± 2.5 2.2 ± 1.3 2.3 ± 2.8 3.9 ± 2.8 0.005
HOMA index>2.5, n (%) 58 (43.9) 11 (30.0) 32 (45.7) 15 (60) 0.008
Total Cholesterol (mg/dL) ±SD 185.7 ± 41.3 179.4 ± 34.0 188.3 ± 44.3 187.8 ± 42.4 ns
HDL-Cholesterol (mg/dL) ±SD 42.3 ± 11.9 41.2 ± 10.9 42.2 ± 13.2 44.4 ± 10.1 ns
LDL-Cholesterol (mg/dL) ±SD 118.4 ± 36.0 116.8 ± 29.1 120.2 ± 36.5 115.9 ± 44.1 ns
Triglycerides(mg/dL) ±SD 123.8 ± 82.5 107.4 ± 54.2 127.7 ± 74.2 137.4 ± 127.3 ns

Vecoli et al.

Vecoli et al. BMC Medical Genetics 2012 13:92   doi:10.1186/1471-2350-13-92

Open Data